OCCIDENT

Key facts

Stages

Seed, Series A, Series C+

Sectors

Biotech & pharma, Healthtech, Other deeptech

Ticket

€500K–€1M

Eligible countries

Not stated

Provider based in

Switzerland

Timing

Rolling applications

Focus

deep tech; life sciences; oncology; neurology; rare diseases

How to apply

Application form · Apply on their site

Source

https://www.occident.group/en/for-founders

Recent deals

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

• Apply linkhttps://www.occident.group/en/pitch-deck-submission | Submit your pitch deck nowhttps://www.occident.group/en/for-founders
• KindAs a venture capital investorhttps://www.occident.group/en/for-founders
• Sectorsdeep tech start-ups in the life sciences sectorhttps://www.occident.group/en/for-founders
• StagesFor an initial investment, we focus on Seed and Series A.https://www.occident.group/en/for-founders
• Ticketstart at 500,000 to 1,000,000https://www.occident.group/en/for-founders
• Ticketstart at 500,000 to 1,000,000https://www.occident.group/en/for-founders

Status history

• 7 Nov 2026: Rolling → Uncertain (profiles: investor activity)
• 6 Nov 2026: Rolling → Uncertain (freshness: investor activity)
• 6 Nov 2026: Rolling (first extraction)
• 6 Nov 2026: Uncertain → Rolling (profiles: investor activity)